The authors evaluated the relationship between vascular endothelial growth factor (VEGF) production, blood vessel extension, and steroidogenesis in small (Ͻ4 mm), medium (4-5 mm), and large (Ͼ5 mm) follicles isolated from gilts treated with eCG. VEGF and estradiol levels were measured in follicular fluid by an enzyme immunoassay and radioimmunoassay, respectively, and then each follicle wall was used to evaluate VEGF mRNA content and for the immunohistochemical analysis of blood vessels. VEGF production was low in small follicles (Ͻ3 ng/ml), high in large follicles (Ͼ10 ng/ml), and markedly differentiated in medium follicles; 44% exhibited values up to 15 ng/ml, whereas the levels never exceeded 3 ng/ml in the remaining aliquot. Medium follicles were then used as a model to investigate angiogenesis. Reverse transcription-polymerase chain reaction for VEGF mRNA demonstrated that granulosa cells represent the main component involved in the production of VEGF. The follicle wall, which presents two distinct concentric vessel networks, showed a vascular area (positive stained area/percent of field area) that was significantly wider in high VEGF follicles than in low VEGF follicles (2.54% ؎ 0.58% vs. 1.29% ؎ 0.58%, respectively). Medium follicles with high VEGF levels and extensive vascularization accumulated high estradiol levels (150-300 ng/ml), whereas follicles with low VEGF levels had basal estradiol levels that never exceeded 30 ng/ml. Early atretic mediumsize follicles had undetectable levels of VEGF and estradiol paralleled by a marked reduction in blood vessel. The data presented propose an improved model for follicle dynamics in which the production of VEGF, stimulated by gonadotropin, creates the vascular conditions required for follicle growth and activity. follicular development, growth factors, mechanisms of hormone action, ovary
INTRODUCTION
Previous investigations have shown that pig antral follicles produce substantial amounts of vascular endothelial growth factor (VEGF) during their growing phase, in re- sponse to gonadotropic stimulation [1] . In the follicle wall, granulosa cells represent the major source of the angiogenic factor in response to FSH stimulation, and secreted VEGF tends to accumulate in the follicle antrum, where it reaches levels as high as 20 ng/ml. This store and the resulting diffusion creates an angiogenic gradient that is likely to regulate the development of the blood vessel network and its architecture within the follicle wall. Follicles are dynamic structures that undergo an impressive increase in volume during the phases that precede ovulation. For a proper growth, efficient compensatory mechanisms that adequate vascular network to the increasing needs of growing follicles is therefore required. A proper blood supply is likely to represent a major regulatory issue that conditions the overall follicle cell function as well as oocyte growth and maturation. In this context the ability of a follicle to produce VEGF may represent an essential, limiting instrument for growth and, as such, it is a distinguishing characteristic of follicles that have overcome selection and have entered the growing follicular pool. In our previous investigation [1] , gonadotropin-inducible VEGF production has been shown to be strictly dependent on follicle size. Following eCG stimulation, small follicles (Ͻ4 mm) had low VEGF levels, large ones (Ͼ5 mm) had uniformly high levels, whereas only a proportion of medium-size follicles (4-5 mm) produced substantial amounts of VEGF, and the remaining were unchanged in their basal production. This suggests that, at about the size of 4-5 mm and under gonadotropin stimulation, the follicle becomes capable of initiating a powerful angiogenic stimulation that could create the conditions required to proceed with its preovulatory growth.
Although the production of VEGF is generally associated with increased blood vessel extension and permeability, the relation between VEGF production and blood supply within the ovary has been mainly speculative. Similarly, the relationship between angiogenesis and follicle cell function is still largely unknown and not supported by experimental evidence, although in cases of abnormal VEGF production such as the ovarian hyperstimulation syndrome, wide disruptions in follicle function have been described [2] . Because angiogenesis and its regulation are likely to play a fundamental role in the control of follicular dynamics, we designed the present research in order to confirm that massive VEGF production is switched on at the 4-to 5-mm size, and to use these structurally homogeneous medium-size follicles to investigate whether the activation of VEGF production induced by hormonal stimulation is accompanied by an increased blood vessel network, and to assess whether this is related to follicle activation. The data presented confirm that VEGF production is switched on in a proportion of 4-to 5-mm follicles and demonstrate that the follicles producing substantial amounts of the angiogenic factor present a wider blood vessel network and activate their steroidogenic machinery.
MATERIALS AND METHODS

Animals and Hormonal Stimulation Protocols
Ten prepubertal Large White gilts with an average weight of 90 kg were divided into two groups of five animals. One group was injected i.m. with 1250 IU of eCG (Folligon, Intervet, Holland) to induce follicular growth and the animals were ovariectomized 40 h later. Untreated gilts were similarly ovariectomized and used as controls. Ovaries were recovered by laparotomy from animals that had been preanesthetized with an injection of azaperone (6 ml/gilt; Stresnil, Janssen, Belgium) and atropine sodium salt (2 mg/gilt; Industria farmaceutica Galenica Senese, Italy) and maintained under tiopenthal sodium (1.5 g/gilt; Pentothal Sodium, Gellini, Italy) anesthesia. All protocols had prior approval of the Ethical Committee of the University of Bologna.
Immediately after ovaries were removed they were transported to the laboratory where single follicles were isolated in dissection medium (Dulbecco phosphate-buffered medium supplemented with 0.4% BSA) with the aid of a stereomicroscope. After measuring the diameter with a calibrated grid, healthy follicles, as indicated by their translucent appearance, limpid follicular fluid, and extensive wall vascularization, were dried on a tissue paper to eliminate any trace of medium, and opened in a 35-mm Petri dish to collect follicular fluid. A proportion of early atretic follicles were also used; they were identified by the dark opaque appearance of the wall and by the looseness of the granulosa layer. The samples of follicular fluid were then frozen individually until they were assayed for VEGF and estradiol-17␤ (E 2 ) content. The remaining follicle wall obtained from each follicle was then transferred in dissection medium and cut into two halves with a razor blade for use in a histological investigation of its blood vessel network and to measure VEGF mRNA.
VEGF Assay
Samples of follicular fluid were measured for their VEGF content by using a specific ELISA (Quantikine; R&D Systems, Minneapolis, MN) that had been previously validated for measurement of porcine VEGF [1] . This highly specific sandwich assay recognizes VEGF 165 as well as VEGF 121, whereas it exhibits negligible cross-reactivity with all cytokines/growth factors tested. A 96-well plate reader (Biomek 1000; Beckman Instruments, Fullerton, CA) set to read at an emission of 450 nm was used to quantify the results. The sensitivity of the assay, obtained by adding two standard deviations to the mean optical density value of 20 standard replicates and calculating the corresponding concentration, is 0.5 ng/ ml of follicular fluid. Intraassay and interassay precision, expressed as the coefficient of variation for replicate determinations of a pooled follicular fluid sample, were 6.4% (10 replicates) and 8.5% (5 replicates), respectively. The levels of VEGF in samples of follicular fluid are expressed as ng/ml of follicular fluid.
VEGF mRNA Expression
Evaluation of VEGF mRNA expression was carried out as previously described [1] . In brief, RNA isolation was performed on granulosa and theca cells that had been previously isolated from a single follicle using a Tri-pure isolation kit (Roche Diagnostics GmbH, Mannheim, Germany). The amount and purity of nucleic acids extracted were spectrophotometrically determined and RNA integrity was tested by reverse transcriptionpolymerase chain reaction (RT-PCR) of ␤-actin.
VEGF primers were selected on the basis of a bovine VEGF sequence (GenBank accession number M32976) that shows 96% homology with pig VEGF sequence (GenBank X81380). They were as follows: 5Ј-CCT GAT GCG GTG CGG GGG CT-3Ј (VEGF-1 nt 779-798) and 5Ј TGG TGG TGG CGG CGG CTA TG-3Ј (VEGF-2 complementary to nt 1197-1216). These primers are able to amplify all VEGF isoforms because their position on the sequence is before and after the splicing site (i.e., nt 966).
Primers for pig ␤-actin were 5Ј-ATC GTG CGG GAC ATC AAG GA-3Ј (ActSS-1) and 5Ј-AGG AAG GAG GGC TGG AAG AG-3Ј (ActSS-2). RT-PCR reactions were conducted as previously described [1] . In brief, equal amounts of total RNA (0.5 g) were retrotranscribed using avian myeloblastosis virus-reverse transcriptase, then PCR reactions for VEGF and ␤-actin were performed on the same cDNA. Products of amplification were separated on agarose gel (1.5%) and visualized by ethidium bromide staining. To confirm the specificity of RT-PCR products we performed a Southern blot using as a probe 40 meroligo (complementary to nt 850-890) labeled with a nonradioactive system (DIG Oligonucleotide 3Ј-End Labeling Kit, Roche) and revealed by chemiluminescent detection. The relative densities of ethidium bromide staining and chemiluminescence were determined by densitometric scanning (Fluor-S-Max; Bio-Rad, Hercules, CA). Beta-actin mRNA has been found in pig follicle cells with levels that are independent of follicle status and size [3] and, as far as we know on the basis of studies in the rat, its expression is not affected by growth factors or gonadotropins [4, 5] . Therefore, VEGF mRNA levels were normalized based on ␤-actin mRNA content and expressed in arbitrary units.
Estradiol Levels in Follicular Fluid
Estradiol levels in follicular fluid were measured by using a validated radioimmunoassay (RIA) [6] . In brief, aliquots of follicular fluid (5 l) from each follicle were diluted in 10 volumes of phosphate buffer and then extracted with 5 ml of diethyl ether. After centrifugation, ether was recovered and dried in a N 2 stream. Dried ether extracts were then resuspended in 250 l of phosphate buffer, and two 100-l aliquots were then assayed in a radioimmunoassay system. Intraassay and interassay precision, expressed as the coefficient of variation for replicate determinations of a pooled follicular fluid sample, were 7.8% (10 replicates) and 11.5% (5 replicates), respectively. The levels of estradiol were expressed as ng/ ml of follicular fluid.
Analysis of the Blood Vessel Network
Blood vessel identification was accomplished by localizing endothelial cells with a specific anti-von Willebrand factor antibody according to the method of Augustin et al. [7] . To this aim, follicle halves isolated for histology were fixed in 10% neutral buffered formalin (NBF) for 12 h at 4ЊC, and subsequently embedded in paraffin wax. Sections (5 m) were cut, placed on poly-L-lysine-coated slides, deparaffinized, rehydrated, and either stained with hematoxylin and eosin, or used for immunohistochemical localization of vascular endothelial cells using a polyclonal rabbit antibody to human von Willebrand factor (Dako, Glostrup, Denmark). Briefly, slides were washed in PBS, and nonspecific peroxidase activity was blocked with 2% hydrogen peroxide (H 2 O 2 ) in methanol for 5 min. Follicle sections were treated with trypsin (1 mg/ml) at room temperature for 25 min. Prior to the addition of the primary antibody, nonspecific binding was blocked by incubating the sections for 30 min in normal goat serum. Excess blocking buffer was rinsed off and the primary antibody was applied at a concentration of 1:400 in PBS containing 1% BSA and incubated overnight at room temperature in a humidified chamber. PBS with 1% BSA was used in place of the primary antisera as a negative control. Free antibody was removed by washing three times with PBS and the secondary biotinylated anti-rabbit antiserum was applied. After washing, sections were incubated for 45 min in the presence of avidin-biotinperoxidase complex (ABC; Vector Laboratories, Burlingame, CA) and the immunoreactivity was visualized using glucose oxidase, diaminobenzidine (DAB), and the nickel ammonium sulphate method [8, 9] .
The Ks300 computed image analysis system (Zeiss, Oberkochen, Germany) was used to conduct a quantitative evaluation of the blood vessels that were positive for von Willebrand factor.
Sections were inspected at low power (100ϫ i.e., 10ϫ objective lens and 10ϫ ocular lens) to assess uniformity of vessel staining. Individual vessels were counted on a 200ϫ field (i.e., 20ϫ objective lens and 10ϫ ocular lens; 442 368 m 2 per field). At least eight randomly selected fields were counted per each section (four sections were analyzed per follicle) to quantify the average of the vascular area (VA; positive stained area/ field area, %). Quantitative evaluation of blood vessel extension was conducted via a retrospective investigation carried out in five high and five medium-low producer VEGF follicles and in four medium-size atretic follicles.
In Vitro Experiments
In order to investigate whether VEGF production recorded in response to eCG stimulation could be dependent on the increased production of E 2 that may follow treatment, medium follicles isolated from ovaries of untreated prepubertal gilts were cultured as follicles in toto [1] without any hormone supplementation (control) or in the presence of eCG (5 IU/ml) or E 2 (500 ng/ml) for 12 h. The culture of follicles in toto under hyperbaric conditions, according to Moor and Trounson [10] , has proven to be a reliable in vitro system for assessing the influence of stimulating agents. In brief, healthy follicles were allocated on a stainless steel grid in a 35-mm Petri dish containing 2 ml of TCM 199 (Sigma Chemical Company, St. Louis, MO), supplemented with 10% fetal calf serum (FCS; Sigma) and 5 g of insulin, transferrin plus sodium selenite (ITS; Sigma). In this way, the follicles supported by the grid emerged from the bottom of the Petri dish by 2-3 mm, thus facilitating gas diffusion. Dishes were then introduced to a hyperbaric chamber and cultured for 12 h in 5% CO 2 and air at 1.2 atm and 39ЊC. At the end of the culture period the follicles were removed and single samples of follicular fluid were collected and stored until they were assayed for VEGF content.
Statistical Analysis
The mean values for VEGF, VEGF mRNA, estradiol, and vascular area were presented as means Ϯ SD and compared with the Student t-test.
Analysis of VEGF levels in follicular fluid was performed in order to identify the distribution of the experimental data. The first step in this analysis was to construct a frequency histogram of the observed data. The construction of such histogram was accomplished by standardizing the experimental data with the following changes in variables: z ϭ x Ϫ /, where z is the new standardized variable, x represents the original data, and are, respectively, the mean and standard deviation of the experimental sample. With this transformation the standardized data sample has zero mean and unitary standard deviation, and the corresponding frequency histogram is shown in Figure 1 , where the maximum displacement from the mean is set at 3.5. We then tested which of the following theoretical distributions would fit the experimental data: 1) the standard normal distribution, 2) a normal distribution with adjustable parameters, and 3) a linear combination of two normal distributions with adjustable parameters. The distribution parameters in the distributions 2 and 3 were calculated with respect to the experimental data by a procedure of nonlinear fit based on the Levenberg Marquardt algorithm, whereas the distribution parameter in scenario 1 was calculated by definition. All these distributions were used to calculate the expected frequencies that were compared with the observed frequencies of each class of the histogram by the chi-square test.
All the analyses described in the previous section were performed with Mathematica software running on a personal computer. All distributions were normalized by direct integration as well as by the probability of each frequency class.
Differences were considered to be significant at P Ͻ 0.05 or less.
RESULTS
VEGF in Follicular Fluid
Unstimulated gilts had a proportion of small (Ͻ4 mm), medium (4-5 mm), and large (Ͼ5 mm) follicles of 40%, 53%, and 7%, respectively. Equine chorionic gonadotropin treatment substantially accelerated follicle dynamics with the following composition recorded 40 h after the treatment: small, 10%; medium, 62%; and large, 28%. In untreated control animals the levels of VEGF were uniformly low, and never exceeded 4 ng/ml regardless of follicle diameter, with an overall mean value of 3.28 Ϯ 1.47 ng/ml (n ϭ 82). By contrast, in eCG-treated animals the VEGF levels recorded in follicular fluid were clearly related to follicle size. Small follicles had levels of the angiogenic factor that were similar to those recorded in untreated animals (3.51 Ϯ 1.23 ng/ml, n ϭ 12), whereas medium follicles displayed a great deal of variation, even within the same ovary, with VEGF levels ranging from 1 to 18 ng/ ml, without any relationship with morphological characteristics of the follicles. The shape of the histogram in Figure  1 is clearly far from the normal distribution and it displays quite pronounced bimodality. In addition, the sum of two gaussians is the only theoretical distribution that gives a significant fit to the experimental data (case 3 2 ϭ 2.05643 P( 2 , 0.05) ϭ 0.841283).
The distribution of the experimental data is therefore bimodal, with 56% of follicles exhibiting low VEGF levels (mean value 3.76 ng/ml, n ϭ 35) and 44% of follicles exhibiting high VEGF levels (mean 13.13 ng/ml; n ϭ 27).
It is interesting that the mean concentration of angiogenic factor analyzed in medium-size follicles that produced low VEGF levels is similar to that recorded in small follicles of treated animals (P Ͼ 0.05) and to the overall concentrations recorded in follicles that were isolated from untreated animals. Medium-size atretic follicles had consistently low levels of VEGF, never exceeding 1 ng/ml. Medium-size follicles represent an ideal model for studying the effect of the angiogenic factor because they are geometrically similar and they came from animals that had the same treatment, whereas they differed markedly in VEGF content. Therefore, the remaining investigations in the present paper were carried out using medium-size follicles classified according to their VEGF content.
VEGF mRNA Content in the Wall of Medium Follicles
Reverse transcription-polymerase chain reaction confirmed that both theca and granulosa cells expressed VEGF 120 and VEGF 164 splice variants. Densitometric values of the two variants, normalized on the ␤-actin mRNA, were summed and considered as a cumulative VEGF mRNA content index.
The levels of mRNA found in granulosa cells were consistent with the levels of VEGF recorded in follicular fluid. The population of medium-size follicles with high concentration of angiogenic factor had, in fact, an mRNA content of 461.12 Ϯ 157.16, compared with 133.71 Ϯ 60.46 (P Ͻ 0.01) recorded in the other follicle pool with low VEGF concentrations (Fig. 2) . In all the follicles examined, regardless of follicle size and treatment, the content mRNA index recorded in theca cells remained remarkably constant and low, ranging between 64.18 and 168.29. VEGF mRNA detection was not carried out in atretic follicles due to the inability to recover all granulosa cells and an expected high incidence of apoptotic cells.
Estrogen Levels in Medium-Size Follicles with High and Low VEGF Levels
Analysis of E 2 levels in follicular fluid was carried out in parallel in order to assess the degree of follicle steroido- genic activation. Estradiol levels in follicles with low VEGF levels were uniformly low with an average concentration of 23.46 Ϯ 19.12 ng/ml. A different situation was recorded in follicles high VEGF levels, in which E 2 ranged between 90 and 265 ng/ml, with a mean value of 173.22 Ϯ 74.56 ng/ml, significantly higher than levels demonstrated in low-VEGF follicles (P Ͻ 0.01). The analysis of correlation revealed that VEGF content and E 2 levels recorded in follicular fluid are positively related (r ϭ 0.89, n ϭ 62, P Ͻ 0.01; see Fig. 3 ). Such a relation was further confirmed by the E 2 content present in atretic follicles that ranged from undetectable levels to values that never exceeded 5 ng/ml.
VEGF Production In Vitro
The levels of VEGF recorded in follicular fluid of medium-size follicles cultured in toto for 12 h rose from 17.59 Ϯ 5.92 ng/ml in control follicles (n ϭ 40) to 51.34 Ϯ 14.56 ng/ml in eCG-treated follicles (n ϭ 38; P Ͻ 0.01), whereas they were entirely unaffected by E 2 stimulation (14.86 Ϯ 3.84 ng/ml, n ϭ 40).
Blood Vessel Distribution
Anti-von Willebrand factor antibody clearly marks endothelial cells and demonstrates that blood vessel architecture is composed of two concentric networks in mediumsize antral follicles; an inner network near the basal membrane, and an outer network within the external theca, connected to each other by anastomotical vessels (Fig. 4) . The total vascular area recorded in high-VEGF follicles was significantly larger than that of low-VEGF follicles (2.54 Ϯ 0.58 vs. 1.29 Ϯ 0.67%; P Ͻ 0.01). In each healthy follicle, inner and outer networks had similar vascular areas and increases in total blood vessel extension recorded in high-VEGF follicles equally involved the two vessel networks ( Table 1 ). The architectures of blood vessels were markedly modified in the wall of medium-size atretic follicles (Fig.  4 and Table 1 ), resulting in an evident reduction of the inner network (0.15 Ϯ 0.08 vs. 0.67 Ϯ 0.34% inner network vascular area in atretic and low-VEGF follicles, respectively; P Ͻ 0.05), whereas the outer network was not modified (0.86 Ϯ 0.44 vs. 0.61 Ϯ 0.38% outer vascular area in atretic and low-VEGF follicles, respectively; P Ͼ 0.05).
DISCUSSION
The data presented here are consistent with previous observations [1] and confirm that VEGF production is regulated differently in follicles according to their size and functional status. Small follicles accumulate very low levels of the factor in follicular fluid, whereas growing follicles that reach the 4-to 5-mm size in response to eCG stimulation initiate copious VEGF production. The levels of VEGF recorded in this class of follicle, showing wide modifications, are not uniformly distributed over the entire range of variation, but show a clear bimodal distribution that can be fit by the sum of two gaussians, thus identifying two distinct populations of medium-size follicles; high-VEGF and low-VEGF producers. The reasons for this difference are presently unknown and investigations are currently underway to asses whether low-VEGF follicles belong to the pool of medium-size follicles, which are already in the ovary at the time of eCG stimulation and, lacking a proper receptor environment, do not grow further, whereas high-VEGF follicles would be units grown to medium size in response to gonadotropin stimulation. Alternatively, this difference may be simply attributable to a different speed with which the follicles organize and activate the VEGF production machinery.
From the data presented, 4-5 mm appears to be the border diameter for the activation of VEGF production that may be required for follicle growth and, in fact, all follicles that have passed this critical size have consistently high levels of VEGF.
Single follicles appear to adopt the strategy of producing specific growth factors in order to create the best conditions for their development and function. This is the case, for instance, in atretic follicles in which nerve growth factor (NGF) production has been switched off, but it is copious in growing follicles under gonadotropin stimulation [11, 12] , and which is probably responsible for the growth of nerve endings in synchrony with the growth of the follicle wall [11] . This would give the nervous system the possi- bility of directing nerve endings proportionally to the perimeter, where they would be innervated without dedicating too much ''attention'' to nongrowing follicles. Similarly, the production of VEGF, enhanced by eCG in developing follicles but switched off in small and early atretic follicles, is likely to drive angiogenesis in order to divert ovarian blood flow from resting or degenerating follicles in favor of growing follicles.
So far, very little information exists that ovarian VEGF production may affect follicle wall vascularization, and this is consistent with other recorded studies [13, 14] . The data presented clearly indicate that among follicles of the same size, those accumulating high levels of VEGF in follicular fluid have a significantly wider vascularization of the follicle wall. No doubt this functional adaptation is advantageous for follicles committed to grow and initiate an intense steroidogenic activity. At present we do not know whether follicles producing VEGF are those that will effectively grow and finally ovulate, but the analysis of E 2 secreted in follicular fluid strongly supports this hypothesis or at least suggests that these follicles will lead to the endocrine scenario of the preovulatory phase. In this context, the positive relationship between VEGF and E 2 production is particularly interesting and further confirms that medium-size follicles can be divided into two distinct follicle pools on the basis of their activity. The correlation between VEGF and E 2 levels is somehow suggestive of a possible cause-andeffect relationship. Indeed, testosterone stimulates VEGF production in prostate [15] and an analogy with ovarian E 2 could be advanced. The in vitro experiments, nevertheless, do not seem to support this hypothesis, showing that E 2 was entirely unable to activate VEGF production in our in vitro system. Although the culture of follicles in toto proved to be a useful model for the study of VEGF production, the variety of endocrine, paracrine, and metabolic signals involved in the control of this growth factor led us to not consider these results as conclusive, and instead, they point to the need for further investigations to clarify the relationship between follicular steroids and VEGF production.
An inverse relationship may be, by converse, supposed. Little doubt exists that activation of steroidogenesis requires an increased supply of nutrients, and VEGF can effectively create these conditions by rising vessel extension. In addition, VEGF can increase vessel permeability and this may be particularly useful for delivering large-size precursors such as lipids or lipoproteins that are used by the follicle cells to build up steroids. Therefore, although the process of steroidogenesis is switched on at the cell level by the proper gonadotropin environment, as shown by a number of in vitro experiments [16, 17] , here we suggest that the massive increase in steroidogenesis that characterizes growing follicles could be dependent on nutrient supply as well, and therefore on VEGF follicular content. Whether VEGF is just one of the factors that are regulated by gonadotropins and takes part in the control of follicle growth, or whether it is a major limiting factor for growth that conditions the execution of the other functions, such as steroidogenesis or cell proliferation, remains at present an open question that warrants further investigation.
The analysis of VEGF mRNA confirms that, as previously shown [1] , eCG stimulates VEGF production in granulosa cells, whereas the theca compartment maintains constant basal mRNA levels independent of the size of the follicle or hormonal stimulation. This production is therefore accumulated in a typically avascular environment, the follicle antrum, where it can reach a particularly high concentration. This is a surprising arrangement whose reasons can only be the object of speculations. It has been hypothesized that VEGF in the follicle antrum slowly diffuses out and creates an angiogenic gradient that attracts blood vessels toward the granulosa [1] . Because vessels cannot cross the barrier represented by the basal membrane, they develop within the theca in strict contact with the basal membrane, thus representing the main source of nutrients and gasses for the granulosa compartment and the germinal cell [18] . The persistence of this inner capillary network, whose importance has been highlighted by Moor and Seamark [19] , appears to depend directly on VEGF accumulation in follicular fluid and when such a store is no longer available, as it occurs in early atretic follicles, it undergoes a marked reduction. By contrast, atresia does not affect the outer vessel network. Because early atresia involves primarily the granulosa layer [20] a presumptive basal thecal VEGF pro-duction might explain this finding. Further investigations are required to establish the cause-and-effect relationship between atresia and blood vessel development. Moreover, because follicles that are actively growing under gonadotropic stimulation produce and accumulate VEGF toward their internal stores, this may represent a strategy aimed to confine the angiogenic effect of the factor to the follicle that produced it, and to avoid that, the nearest follicles could take advantage of this production by increasing their vascularization and hence their developmental potential. In this context, the follicle appears as an autonomous unit engaged in a competition for growth, ovulation, and VEGF production, and could be a prevalent parameter of selection.
In conclusion, the present investigation has shown that under proper hormonal stimulation, pig follicles start producing substantial amounts of VEGF when they reach the 4-to 5-mm size. This is not a generalized response but, interestingly, those follicles that activate VEGF synthesis increase their blood vessel extension and activate steroidogenesis, thus pointing to VEGF production as a crucial event in the control of follicle dynamics.
